Medifast INC Schedule 13G passive stakes

Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC have collectively acquired a 5.3% stake in Medifast, Inc., holding 587,214 shares as of June 30, 2026.

Charles Schwab Investment Management Inc. has reported a change in its beneficial ownership of Medifast Inc. common stock, now holding 3.6% of the class.

Citadel Securities and affiliated entities have filed a Schedule 13G reporting a 6.5% beneficial ownership stake in Medifast, Inc.

Charles Schwab Investment Management has reported an increase in its beneficial ownership of MediFast Inc. common stock, now holding 5.74% of the class.

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have filed a Schedule 13G, reporting beneficial ownership of 773,710 shares of Medifast Inc. common stock, representing 6.96% of the class.

The Vanguard Group reports 0% beneficial ownership in Medifast Inc. following an internal realignment.

G1 Execution Services, Susquehanna Fundamental Investments, and Susquehanna Securities collectively reported a 1.4% beneficial ownership in Medifast, Inc. as of December 31, 2025.

Charles Schwab Investment Management Inc. has reported a 7.06% beneficial ownership stake in Medifast Inc. common stock as of December 31, 2025.

A group of Susquehanna-affiliated entities has reported a 6.0% beneficial ownership stake in Medifast, Inc., totaling 654,945 shares.

Charles Schwab Investment Management Inc. has reported a 5.41% passive ownership stake in Medifast Inc. common stock.

A group of Susquehanna-affiliated entities has disclosed a 7.2% passive ownership stake in Medifast, Inc., totaling 785,606 shares.

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.09% in Medifast Inc.'s common stock.